Trial Profile
A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077-3201-2TBS in Healthy Subjects and Type 2 Diabetic Subjects.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs SER 150 (Primary) ; Aspirin
- Indications Diabetic angiopathies; Diabetic complications; Thrombosis
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Pharmacokinetics; Therapeutic Use
- 03 Jun 2013 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 05 Sep 2012 Status changed from recruiting to suspended, as reported by European Clinical Trials Database.
- 29 Aug 2012 Evolva Holding SA is consulting with German regulatory authority BfArM concerning liver enzyme elevations associated with EV 077, as reported in a media release from Evolva Holding SA.